Nureca Limited , a prominent player in the healthcare and wellness sector, has announced a significant change in its leadership team. Chief Financial Officer (CFO) Naresh Gupta has tendered his resignation, marking the end of his tenure with the company.

Key Details of the Resignation

Corporate Governance and Disclosure

In adherence to regulatory requirements, Nureca Limited has promptly informed the stock exchanges about this development. The company has filed the necessary intimation with both the BSE Limited and the National Stock Exchange of India Limited, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transition Period

The extended notice period of approximately three months provides Nureca Limited with ample time to ensure a smooth transition. This period allows the company to potentially identify and onboard a successor, ensuring continuity in financial leadership.

Additional Insights

• Nureca Limited has confirmed that apart from the reasons mentioned in Gupta's resignation letter, there are no other material reasons for his departure.
• The company's proactive disclosure aligns with best practices in corporate governance, maintaining transparency with its shareholders and the market at large.
• This announcement comes just days before Nureca's scheduled board meeting on October 16, 2025, where the company plans to consider and approve its unaudited financial results for the second quarter and half-year ended September 30, 2025.

As Nureca Limited navigates this transition in its financial leadership, stakeholders will likely be keen to observe any potential impacts on the company's financial strategy and performance in the coming quarters. The market will also be watching closely for announcements regarding Gupta's successor in the CFO role.

Nureca Limited , a prominent player in the healthcare and medical equipment sector, has announced significant corporate restructuring moves aimed at streamlining operations and enhancing shareholder value.

Merger with Nureca Technologies Private Limited

The Board of Directors of Nureca Limited has approved a draft scheme for the merger by absorption of its wholly owned subsidiary, Nureca Technologies Private Limited. This strategic decision, made on May 20, 2025, is subject to necessary statutory and regulatory approvals.

Financial Snapshot

The financial details of both entities involved in the merger are as follows:

Rationale Behind the Merger

The merger is expected to bring several benefits to the company and its stakeholders:

1. Improved operational efficiency
2. Elimination of inter-corporate dependencies
3. Minimization of administrative compliances
4. Maximization of shareholder value through reduced overheads
5. Simplification of the group structure

It's important to note that no new shares will be issued as part of this scheme, and there will be no change in the shareholding pattern of Nureca Limited.

Strike-Off of Nureca Healthcare Private Limited

In addition to the merger, Nureca Limited has also approved the strike-off of another wholly owned subsidiary, Nureca Healthcare Private Limited. This subsidiary is described as non-material and non-functional.

The company stated that the strike-off of Nureca Healthcare Private Limited will contribute to achieving a simplified corporate structure, uniformity in corporate policy, and reduction of entities in the group. This move is expected to decrease managerial overlaps and increase overall efficiency.

Regulatory Compliance

As per the SEBI Listing Regulations, Nureca Limited has filed the necessary documents with the stock exchanges for dissemination. These include:

1. Copy of the Scheme of Merger
2. Outcome of the Board Meeting approving the Draft Scheme
3. Certified True Copy of the Extract of the Resolution passed by the Board of Directors

The company has emphasized that the merger scheme is exempt from obtaining a 'No Objection Letter' from the Stock Exchange, as it involves the merger of a wholly owned subsidiary with its holding company.

Conclusion

These strategic moves by Nureca Limited reflect the company's commitment to optimizing its corporate structure and enhancing operational efficiency. As the healthcare sector continues to evolve, such restructuring efforts may position Nureca Limited to better capitalize on market opportunities and drive long-term growth.

Investors and stakeholders will be keenly watching the progress of these corporate actions and their impact on the company's future performance.